51. Non-animal derived recombinant collagen-based biomaterials as a promising strategy towards adipose tissue engineering.
- Author
-
Van Damme L, Blondeel P, and Van Vlierberghe S
- Subjects
- Humans, Animals, Materials Testing, Methacrylates chemistry, Collagen chemistry, Polyesters chemistry, Printing, Three-Dimensional, Elastic Modulus, Collagen Type I chemistry, Oligopeptides chemistry, Cell Differentiation drug effects, Mesenchymal Stem Cells cytology, Adipocytes cytology, Adipocytes metabolism, Adipogenesis drug effects, Cell Proliferation, Tissue Engineering methods, Adipose Tissue cytology, Adipose Tissue metabolism, Tissue Scaffolds chemistry, Biocompatible Materials chemistry, Biocompatible Materials pharmacology, Gelatin chemistry, Recombinant Proteins
- Abstract
Adipose tissue engineering (ATE) has been gaining increasing interest over the past decades, offering promise for new and innovative breast reconstructive strategies. Animal-derived gelatin-methacryloyl (Gel-MA) has already been applied in a plethora of TE strategies. However, due to clinical concerns, related to the potential occurrence of immunoglobulin E-mediated immune responses and pathogen transmission, a shift towards defined, reproducible recombinant proteins has occurred. In the present study, a recombinant protein based on human collagen type I, enriched with arginine-glycine-aspartic acid was functionalized with photo-crosslinkable methacryloyl moieties (RCPhC1-MA), processed into 3D scaffolds and compared with frequently applied Gel-MA from animal origin using an indirect printing method applying poly-lactic acid as sacrificial mould. For both materials, similar gel fractions (>65%) and biodegradation times were obtained. In addition, a significantly lower mass swelling ratio (17.6 ± 1.5 versus 24.3 ± 1.4) and mechanical strength (Young's modulus: 1.1 ± 0.2 kPa versus 1.9 ± 0.3 kPa) were observed for RCPhC1-MA compared to Gel-MA scaffolds. In vitro seeding assays showed similar cell viabilities (>80%) and a higher initial cell attachment for the RCPhC1-MA scaffolds. Moreover, the seeded adipose-derived stem cells could be differentiated into the adipogenic lineage for both Gel-MA and RCPhC1-MA scaffolds, showing a trend towards superior differentiation for the RCPhC1-MA scaffolds based on the triglyceride and Bodipy assay. RCPhC1-MA scaffolds could result in a transition towards the exploitation of non-animal-derived biomaterials for ATE, omitting any regulatory concerns related to the use of animal derived products., (© 2024 IOP Publishing Ltd. All rights, including for text and data mining, AI training, and similar technologies, are reserved.)
- Published
- 2024
- Full Text
- View/download PDF